Literature DB >> 2014879

Comparison of newborn screening records and birth certificates to estimate bias in newborn HIV serosurveys.

K A Pass, L M Schedlbauer, P A MacCubbin, D M Glebatis.   

Abstract

Implicit in the New York State Newborn HIV Seroprevalence Study is the assumption that newborns of all New York State residents are tested for human immunodeficiency virus (HIV) antibodies. We examined this assumption by describing that part of the 1988 New York newborn population not tested in the HIV seroprevalence study and assessing any bias contributed by this group. Of the expected total HIV specimens 1.5 percent were never received by the Newborn Screening Program, 0.5 percent were invalid specimens for which no repeat specimen could be obtained, and 1.7 percent were unsuitable or of insufficient quantity to be tested for HIV antibody. Thus 96.3 percent of all 1988 New York newborns were tested for HIV antibody. Black infants from New York City and low-birthweight infants were represented disproportionately among those not tested. Assignment of all untested newborn to HIV-positive status increased the seroprevalence rate 17 percent (0.64 percent to 0.75 percent).

Entities:  

Mesh:

Year:  1991        PMID: 2014879      PMCID: PMC1404758          DOI: 10.2105/ajph.81.suppl.22

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  4 in total

1.  Improving estimates of HIV-1 seroprevalence among childbearing women: use of smaller blood spots.

Authors:  N J Hoxie; J M Vergeront; J R Pfister; G L Hoffman; P A Markwardt-Elmer; J P Davis
Journal:  Am J Public Health       Date:  1992-10       Impact factor: 9.308

2.  Newborn seroprevalence study: methods and results.

Authors:  L F Novick; D M Glebatis; R L Stricof; P A MacCubbin; L Lessner; D S Berns
Journal:  Am J Public Health       Date:  1991-05       Impact factor: 9.308

3.  Impact of incomplete coverage of neonatal dried blood spot screening on estimating HIV-1 seroprevalence.

Authors:  E J Hutchinson; A Streetly; C Grant; R Pollitt; P Eldridge; A Nicoll
Journal:  Epidemiol Infect       Date:  1996-08       Impact factor: 2.451

4.  Standardization of ELISA protocols for serosurveys of the SARS-CoV-2 pandemic using clinical and at-home blood sampling.

Authors:  Carleen Klumpp-Thomas; Heather Kalish; Matthew Drew; Sally Hunsberger; Kelly Snead; Michael P Fay; Jennifer Mehalko; Anandakumar Shunmugavel; Vanessa Wall; Peter Frank; John-Paul Denson; Min Hong; Gulcin Gulten; Simon Messing; Jennifer Hicks; Sam Michael; William Gillette; Matthew D Hall; Matthew J Memoli; Dominic Esposito; Kaitlyn Sadtler
Journal:  Nat Commun       Date:  2021-01-04       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.